Yolundi Cloete

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Adam Penn‐Nicholson, Stanley Kimbung Mbandi, Ethan Thompson et al. · Scientific Reports · 2020 · 171 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of <i>Mycobacterium tuberculosis</i> Infection

Elisa Nemes, Virginie Rozot, Hennie Geldenhuys et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 168 citations · Full text

Public Health, Immunology, Infectious Diseases +16

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michèle Tameris, Helen Mearns, Adam Penn‐Nicholson et al. · The Lancet Respiratory Medicine · 2019 · 137 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Tracey A. Day, Adam Penn‐Nicholson, Angelique Kany Kany Luabeya et al. · The Lancet Respiratory Medicine · 2020 · 103 citations

Veterinary Medicine, Immunology, Infectious Diseases +10

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

Munyaradzi Musvosvi, Huang Huang, Chunlin Wang et al. · Nature Medicine · 2023 · 100 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17